Respiratory disorders
Encorium has performed more than 20 studies in the respiratory area involving over 2,500 patients at 241 international sites. We have conducted Phase I-IV studies in asthma with a Core Team with extensive operational experience in both adult and pediatric asthma trials. Drug classes include inhaled glucocorticosteroid or B2 agonist, Anti IgE, protein peptides, medical device (delivery system) GCRP IA&IB.
In addition, we have conducted 8 studies in COPD and smoking cessation.
Contact Us
For enquiries on Encorium's services and capabilities, please contact info@encorium.com alternatively contact your local Encorium operations (see the site location map).
Encorium Headquarter
Encorium Oy
Keilaranta 10
FI-02150 Espoo
Finland
Tel: +358 20 751 8200
Fax:
Clinical Department
+358 20 751 8250
Administration
+358 20 751 8255
info@encorium.com